A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 232 participants.

Also called NCT04955990

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 232 participants (enrolled count) (from the registry)
Sponsor
  • Actelion Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04955990
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Argentina, Brazil, Canada, China, Germany, Italy, Japan, Malaysia, Netherlands, Poland, Puerto Rico, Singapore, South Korea, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04955990. Allocation not applicable; no masking; primary purpose other. Start 2021-10-14 (actual); primary completion 2022-12-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
Acronym
CARE PAH
Condition
Pulmonary Arterial Hypertension
Intervention (Other)
PAH Therapies
Lead sponsor
Actelion (class: industry)

Record details

Record id
cardio:ct-nct04955990
Content hash
8c4fb86995cc30701d252bad7cefbdf54f3501936e5c5977d3b0c58c851aa7fb